Dr. Sheraz Markar
Division of Surgery.
Imperial College, London, UK.
Dr. Klara Nilsson
Division of Surgery. Karolinska Institute and Centre for Digestive Diseases
Stockholm, Sweden.
Prolonged time to surgery reduces the risk of postoperative complications after Neoadjuvant Chemoradiotherapy for cancer of the Esophagus or Gastroesophageal junction
– Based on a national data registry
Dr. Fredrik Klevebro
Division of Surgery. Karolinska Instituted and Centre for Digestive Diseases
Stockholm, Sweden
Neodjuvant Chemotherapy vs. Neoadjuvant Chemoradiation for Cancer of the Oesophagus or Gastro-Oesophageal Junction: A randomized Clinical Trial
The European Society for Esophageal Disease 2022